
Schott Pharma Invests in Sterile Cartridge Production
Schott Pharma is investing more than €100 million in its existing site in Lukácsháza, Hungary, to expand its capacity for sterile ready-to-use (RTU) cartridges.
Schott Pharma is investing more than €100 million in its existing site in Lukácsháza, Hungary, to expand its capacity for sterile ready-to-use (RTU) cartridges.
DuPont announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica.